Moreover, the patients with higher expression of MSI2 or (and) HMGB1 also had a longer overall survival in GEPIA CRC datasets (HR = 0.62, Log rank p = 0.032; HR = 0.58, Log rank p = 0.013) (Fig. 7M). This evidence concerns the gene HMGB1 and colorectal carcinoma.